Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Textron Profit Rises Amid Higher Demand For Commercial Aircraft - Update

RELATED NEWS
Trade TXT now with 

Business jets maker Textron Inc. (TXT: Quote) on Wednesday reported a significant increase in profit for the first quarter, amid improvement in demand for commercial aircraft and industrial products. Earnings and revenues topped Wall Street estimates. The company confirmed its full year outlook.

Net income for the quarter surged to $118 million or $0.40 per share from $29 million or $0.09 per share last year.

Income from continuing operations increased to $0.41 per share from $0.10 per share in the prior year. On average, 13 analysts polled by Thomson Reuters expected the company to earn $0.35 per share for the quarter. Analysts' estimates typically exclude special items.

Revenues increased to $2.86 billion from $2.48 billion. Analysts had a consensus revenue estimate of $2.70 billion for the quarter.

Revenues at Cessna increased 20 percent to $669 million. The increase reflects the delivery of 38 new Citation jets compared to 31 in last year's first quarter, as well as higher aftermarket volumes.

Bell revenues were $994 million, up about 33 percent from last year. Bell delivered 30 commercial aircraft in the quarter, up from 15 commercial units last year. The division also delivered more 10 V-22's and 7 H-1's in the just concluded quarter.

Textron Chairman and CEO Scott Donnelly said, "The demand environment for our commercial aircraft and industrial products continued to improve, which reinforces our confidence in our outlook for the year."

Textron reiterated its 2012 guidance of earnings per share from continuing operations of $1.80 to $2.00 and revenues of around $12.5 billion. Analysts expect the company to earn $1.91 per share on revenues of $12.35 billion for the year.

TXT closed on Tuesday at $27.65, up from the prior close of $27.01, on a volume of 3.78 million shares. The stock is up 1 percent in pre-market activity.

Register
To receive FREE breaking news email alerts for Textron Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.